Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Biogen
Biotech
Topics

Advertisement

Biogen

Share

Top Latest Popular

Yesterday

Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast FiercePharma 14:19 Fri, 12 Jun

Wednesday

How Is Biogen’s Stock Performance Compared to Other Biotech Stocks? Barchart 12:07 Wed, 10 Jun

Monday

Biogen To End Investors' Alzheimer's Drug Case For $18.9M Law360 23:33 Mon, 08 Jun

Advertisement

Advertisement

Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story Benzinga 17:19 Mon, 08 Jun

This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday Benzinga 15:01 Mon, 08 Jun

In the last month

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA PMLiVE 13:11 Fri, 05 Jun

Biogen’s salanersen gains FDA breakthrough therapy designation for SMA Pharmaceutical Technology 10:20 Fri, 05 Jun

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm Business Wire (Press Release) 02:07 Fri, 05 Jun

Fnih Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award Business Wire (Press Release) 13:02 Thu, 04 Jun

EULAR 26 hears of treatment advances in lupus pharmaphorum 12:46 Thu, 04 Jun

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Biogen (Press Release) 12:37 Thu, 04 Jun

Biogen And UCB Present Positive Phoenycs go Data For Dzp In Treating Lupus RTT News 11:40 Thu, 04 Jun

Communiqué de presse : Sanofi fédère l'écosystème de santé pour accélérer le diagnostic des maladies rares en France : Biogen rejoint accelRare Sanofi (Press Release) 09:17 Thu, 04 Jun

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus Biogen (Press Release) 06:01 Thu, 04 Jun

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses Biogen (Press Release) 12:40 Wed, 03 Jun

Advertisement

Biogen Acquisition of Apellis Spells End to Derivative Lawsuit Bloomberg Law 21:08 Mon, 01 Jun

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus Biogen (Press Release) 06:35 Mon, 01 Jun

A Look At Biogen (BIIB) Valuation After Earnings Beat And Parkinson’s Setback Simply Wall St 18:17 Sat, 30 May

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD? Zacks 16:02 Fri, 29 May

Biogen Announces Webcast of Annual Meeting of Stockholders Biogen (Press Release) 21:11 Thu, 28 May

Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims FiercePharma 12:40 Wed, 27 May

Italy probes Biogen for allegedly hindering sales of rival's MS drug The Tribune, California 09:55 Wed, 27 May

Italy's antitrust regulator opens probe into US Biogen over alleged dominant position Rock Hill Herald 07:50 Wed, 27 May

Biogen and Denali discontinue Parkinson’s candidate BIIB122 after Phase IIb LUMA study miss Manufacturing Chemist 08:07 Mon, 25 May

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails Zacks 18:17 Fri, 22 May

Biogen, Denali Discontinue BIIB122 Development In Idiopathic Parkinson’s After Phase IIb Miss Scrip Pharma Intelligence 15:08 Fri, 22 May

Biogen and Denali report Phase IIb LUMA trial data for Parkinson’s Clinical Trials Arena 11:40 Fri, 22 May

Biogen And Denali Halt Development Of BIIB122 After Phase 2b Luma Study Misses Key Goals RTT News 09:19 Fri, 22 May

Biogen, Denali pull Parkinson's drug after failed trial pharmaphorum 08:57 Fri, 22 May

Biogen, Denali scrap Parkinson's drug after failure in mid-to-late stage study Rock Hill Herald 08:25 Fri, 22 May

Investor alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB PR Newswire (Press Release) 23:45 Thu, 21 May

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease Biogen (Press Release) 23:07 Thu, 21 May

Biogen Patent Suit Targets Somerset’s Copy of Spinraza Therapy Bloomberg Law 21:36 Thu, 21 May

Apellis soars on Biogen deal as biopharma index trails the market BioWorld 21:33 Thu, 21 May

Are Wall Street Analysts Bullish on Biogen Stock? Barchart 13:47 Wed, 20 May

BIIB Investor Alert: Levi & Korsinsky Investigates Biogen Inc. (BIIB) for Potential Securities Fraud Business Wire (Press Release) 21:07 Tue, 19 May

Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout Proactive Investors (US) 14:38 Tue, 19 May

Goldman Sachs raises Biogen price target to $250 on Leqembi surge Lexington Herald-Leader, Kentucky 18:47 Sun, 17 May

BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal Zacks 17:32 Fri, 15 May

Biogen forges on with Alzheimer’s therapy development despite Phase II miss Clinical Trials Arena 11:41 Fri, 15 May

Advertisement

Advertisement

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna